{
  "primary": "ATXN3",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 2,
  "support_summary": "ATXN3 expression levels modulate the accumulation and phosphorylation of TDP-43, suggesting a functional, likely indirect, regulatory relationship.",
  "functions": [
    {
      "function": "TDP-43 C-Terminal Fragment Clearance",
      "arrow": "activates",
      "cellular_process": "ATXN3 is involved in a protein quality control pathway that clears toxic, phosphorylated C-terminal fragments of TDP-43. These fragments are a key pathological hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).",
      "effect_description": "ATXN3 plays a protective role by promoting the clearance of toxic TDP-43 species. Loss of ATXN3 function leads to the accumulation and phosphorylation of these fragments, linking SCA3 pathology to the broader spectrum of TDP-43 proteinopathies.",
      "biological_consequence": [
        "Clearance of Phosphorylated TDP-43 Fragments → Reduced Proteotoxicity → Neuroprotection"
      ],
      "specific_effects": [
        "ATXN3 overexpression reduces accumulation of TDP-43 C-terminal fragments",
        "ATXN3 knockdown increases accumulation of toxic TDP-43 fragments",
        "Phosphorylated TDP-43 inclusions are found in SCA3 mouse models"
      ],
      "evidence": [
        {
          "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
          "year": 2022,
          "pmid": "38497605"
        },
        {
          "paper_title": "Plasma PolyQ-ATXN3 Levels Associate With Cerebellar Degeneration and Behavioral Abnormalities in a New AAV-Based SCA3 Mouse Model",
          "year": 2021,
          "pmid": "35386195"
        }
      ],
      "_context": {
        "type": "indirect",
        "query_protein": "TARDBP",
        "chain": []
      },
      "interaction_effect": "activates",
      "direction": "main_to_primary",
      "interaction_direction": "main_to_primary",
      "pmids": [
        "38497605",
        "35386195"
      ],
      "function_effect": "activation"
    }
  ],
  "arrow": "regulates",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "_chain_inferred": true,
  "mechanism": "ATXN3 is involved in a protein quality control pathway that clears toxic, phosphorylated C-terminal fragments of TDP-43. These fragments are a key pathological hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).",
  "effect": "ATXN3 plays a protective role by promoting the clearance of toxic TDP-43 species. Loss of ATXN3 function leads to the accumulation and phosphorylation of these fragments, linking SCA3 pathology to the broader spectrum of TDP-43 proteinopathies.",
  "summary": "ATXN3 activates TARDBP to modulate tdp-43 c-terminal fragment clearance, ultimately affecting neuroprotection.",
  "evidence": [
    {
      "paper_title": "The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases",
      "year": 2022
    },
    {
      "paper_title": "Plasma PolyQ-ATXN3 Levels Associate With Cerebellar Degeneration and Behavioral Abnormalities in a New AAV-Based SCA3 Mouse Model",
      "year": 2021
    }
  ],
  "interaction_effect": "regulates",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 3
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 --regulates--> TARDBP:",
  "protein_a": "TARDBP",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-11-24T02:27:04.780723Z",
  "last_updated": "2025-11-24T02:27:04.780723Z"
}